2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | - | 0 | 5.652 | 98.778 | 99.421 | 349.689 |
Total Income - EUR | - | - | - | - | - | 0 | 37.004 | 98.820 | 99.609 | 350.059 |
Total Expenses - EUR | - | - | - | - | - | 2.516 | 84.229 | 60.747 | 55.370 | 202.778 |
Gross Profit/Loss - EUR | - | - | - | - | - | -2.516 | -47.225 | 38.072 | 44.239 | 147.282 |
Net Profit/Loss - EUR | - | - | - | - | - | -2.516 | -47.595 | 36.242 | 43.573 | 144.408 |
Employees | - | - | - | - | - | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Nephroroc S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 750.477 | 787.546 | 819.788 | 856.540 | 71.536 | - | - | - | - | - |
Current Assets | - | - | - | - | - | 6.469 | 195.168 | 389 | 11.066 | 7.301 |
Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Receivables | - | - | - | - | - | 2.000 | 191.570 | 0 | 10.977 | 7.006 |
Cash | - | - | - | - | - | 4.469 | 3.599 | 389 | 89 | 295 |
Shareholders Funds | - | - | - | - | - | -2.474 | -50.022 | -12.671 | 30.862 | 144.456 |
Social Capital | - | - | - | - | - | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | - | 80.479 | 1.101.731 | 832.886 | 767.835 | 613.487 |
Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "6820 - 6820" | |||||||||
CAEN Financial Year | 6820 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.